HYAL4 has been noted to be involved in cancer; a defective HYAL4 mechanism may underlie the formation of various cancers, and thus, the swift investigation of HYAL4 in more cancers could provide beneficial insight and a novel, specific treatment target for a variety of cancer patients, including the treatment of acute spinal cord injuries [49,50]. This evidence concerns the gene HYAL4 and cancer.